Olmesartan medoxomil and hydrochlorothiazide tablet packaging device

Abstract

The utility model discloses an olmesartan medoxomil and hydrochlorothiazide tablet packaging device, which relates to the technical field of tablet packaging, and comprises a packaging bottle and a sealing cover, a sealing ring is fixedly arranged below the sealing cover, the sealing ring is in threaded connection with an upper opening of the packaging bottle, the upper part of the sealing cover is a collecting cavity, a sliding table is arranged at the top of the collecting cavity, and the sliding table is strip-shaped; a through medicine outlet is formed in the middle of the sliding table, sliding rails are arranged on the sliding table and located on the front side and the rear side of the medicine outlet, a sliding frame is slidably arranged on the sliding rails, a transparent cover is fixedly arranged on the upper surface of the sliding frame, and a concave separation groove is formed in the side edge of the sliding table and located between the sliding rails. The novel olmesartan medoxomil and hydrochlorothiazide tablet bottle is simple in structure, according to the shape and characteristics of olmesartan medoxomil and hydrochlorothiazide tablets, the tablets are packaged through the bottle body, a single tablet can be taken out when the tablets are taken out, the problems that too many tablets are poured out, the bottle cap is frequently opened, and the tablets are affected with damp can be solved, practicability is high, and the novel olmesartan medoxomil and hydrochlorothiazide

Description

Technical Field

[0001] The utility model belongs to the technical field of tablet packaging, and particularly relates to an olmesartan medoxomil and hydrochlorothiazide tablet packaging device. Background Art

[0002] Olmesartan medoxomil and hydrochlorothiazide tablets are a compound preparation composed of olmesartan medoxomil and hydrochlorothiazide, and are mainly used for treating hypertension clinically. The tablets are film-coated tablets, white in color after removing the coating, and are in the shape of flakes and are solids. Existing olmesartan medoxomil and hydrochlorothiazide tablets are mostly packaged in bottles or aluminum-plastic packaging boards.

[0003] The number of tablets packaged by the packaging board is small and the production cost is high. When the tablets packaged in the bottle are poured out, it is easy to pour out too many tablets, causing external environmental pollution to the tablets, and frequently opening the bottle cap easily leads to moisture inside the medicine bottle, etc. Summary of the Utility Model

[0004] The purpose of the utility model is to provide an olmesartan medoxomil and hydrochlorothiazide tablet packaging device, which has a simple structure. In view of the shape and characteristics of olmesartan medoxomil and hydrochlorothiazide tablets, the tablets are packaged in a bottle, and single tablets can be taken out when taking medicine, which can avoid problems such as pouring out too many tablets and moisture of the tablets caused by frequently opening the bottle cap. It has strong practicability and is suitable for popularization.

[0005] The utility model provides the following technical solution: an olmesartan medoxomil and hydrochlorothiazide tablet packaging device, including a packaging bottle and a closing cover. A sealing ring is fixedly arranged below the closing cover, and the sealing ring is threadedly connected to the upper mouth of the packaging bottle. The upper part of the closing cover is a converging cavity, and a sliding table is arranged at the top of the converging cavity. The sliding table is in a long strip shape;

[0006] A through medicine outlet is arranged in the middle of the sliding table. Slide rails are arranged on both sides of the medicine outlet on the sliding table. A sliding frame is slidably arranged on the slide rails. A transparent cover is fixedly arranged on the upper surface of the sliding frame. A concave separation groove is arranged on the side of the sliding table between the slide rails.

[0007] Preferably, the transparent cover covers the medicine outlet and the separation groove. The sliding frame is hermetically connected to the slide rails, and the left and right side frames of the sliding frame are hermetically connected to the upper surface of the sliding table.

[0008] Preferably, a clamping groove is arranged on one side of the sliding frame away from the separation groove. A lower groove is arranged on one side of the sliding table at the medicine outlet. A clamping block is fixedly arranged in the lower groove through a transverse elastic rod. The position of the clamping block is opposite to that of the clamping groove, and inclined sliding surfaces are arranged on both sides of the clamping block. When the clamping block is stuck in the clamping groove, the transparent cover covers the medicine outlet and the separation groove. The length of the slide rail satisfies that the transparent cover can slide along the slide rail to expose the separation groove outside.

[0009] Preferably, the depth and shape of the separation groove are such that only one olmesartan medoxomil and hydrochlorothiazide tablet can lie flat inside it.

[0010] Advantages of the present utility model: The structure is simple. In view of the shape and characteristics of the olmesartan medoxomil and hydrochlorothiazide tablets, the tablets are encapsulated in a bottle body, and when taking the medicine, the tablets can be taken out one by one, which can avoid problems such as pouring out too many tablets and frequent opening of the bottle cap resulting in the tablets getting damp. The practicability is strong, specifically as follows:

[0011] (1). The present utility model is provided with a separation groove. When the olmesartan medoxomil and hydrochlorothiazide tablets are placed in the encapsulation bottle and it is necessary to pour out the tablets, the encapsulation bottle is turned over so that the tablets enter the transparent cover from the medicine outlet. Then the encapsulation bottle is tilted towards the separation groove, so that the tablets coming out of the transparent cover slide to the separation groove. Shake the encapsulation bottle to make the tablets below fall into the separation groove. The depth of the separation groove can only hold one tablet. Then push the transparent cover to make it slide along the slide rail, and push the tablets in the transparent cover towards the medicine outlet, thereby leaving the tablet in the separation groove. After the transparent cover is pushed away, the separation groove is exposed, and the tablet in the separation groove can be poured out, thus preventing the pouring out of too many tablets.

[0012] (2). The present utility model is provided with a transparent cover. The closed cover is connected to the encapsulation bottle through a sealing thread. When pouring out the tablets, it is not necessary to open the closed cover. By pushing the transparent cover, one tablet can be separated and poured out. Moreover, the sliding frame on the transparent cover is hermetically connected to the sliding frame, and the part covering the sliding table is also airtight with the sliding table, so that the transparent cover remains sealed with the closed cover in the normal state. During the process of pouring out the tablets, only the air at the separation groove will enter the encapsulation bottle, which can effectively reduce the entry of external air. When the transparent cover is reset, the inclined surface on the clamping block is squeezed, and the elastic rod undergoes elastic deformation downward to allow the sliding frame to pass through. After the clamping block is clamped into the card slot, it can prevent the transparent cover from sliding, thereby ensuring the stability of the transparent cover. Description of the Drawings

[0013] The drawings are used to provide a further understanding of the present utility model and constitute a part of the specification. They are used together with the embodiments of the present utility model to explain the present utility model and do not constitute a limitation to the present utility model. In the drawings:

[0014] Figure 1 is the overall schematic diagram of the present utility model;

[0015] Figure 2 is the cross-sectional view of the present utility model;

[0016] Figure 3 is the enlarged view of part A of the present utility model;

[0017] The labels in the figure are: 1, encapsulation bottle; 2, sealing cover; 3, converging cavity; 4, sliding table; 5, medicine outlet; 6, separation groove; 7, slide rail; 8, sealing ring; 9, transparent cover; 10, sliding frame; 11, card slot; 12, lower groove; 13, elastic rod; 14, clamping block. Specific implementation manner

[0018] Next, the technical solutions in the embodiments of the present invention will be clearly and completely described in conjunction with the accompanying drawings in the embodiments of the present invention; obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without making creative efforts shall fall within the protection scope of the present invention.

[0019] In the description of the present invention, it should be noted that the orientation or positional relationship indicated by the terms "upper", "lower", "inner", "outer", "top / bottom end", etc. is based on the orientation or positional relationship shown in the accompanying drawings, and is only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore should not be construed as a limitation of the present invention.

[0020] In the description of the present invention, it should be noted that unless otherwise clearly defined and limited, the terms "installed", "provided with", "sheathed / connected", "connected", etc. should be understood in a broad sense. For example, "connected" can be a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be directly connected or indirectly connected through an intermediate medium, and it can be the communication inside two elements. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood according to specific circumstances.

[0021] Now, in conjunction with the accompanying drawings of the specification, the structural features of the present invention will be described in detail.

[0022] See Figure 1-2, An olmesartan medoxomil and hydrochlorothiazide tablet encapsulation device, comprising an encapsulation bottle 1 and a closing cap 2. A sealing ring 8 is fixedly provided below the closing cap 2, and the sealing ring 8 is threadedly connected to the upper mouth of the encapsulation bottle 1. The closing cap 2 is connected to the encapsulation bottle 1 through the sealing ring 8. The upper part of the closing cap 2 is a converging cavity 3. A sliding table 4 is provided at the top of the converging cavity 3. The sliding table 4 is strip-shaped, enabling the mechanisms thereon to slide horizontally. A through medicine outlet 5 is provided in the middle of the sliding table 4. Slide rails 7 are provided on both sides of the sliding table 4 before and after the medicine outlet 5. A sliding frame 10 is slidably provided on the slide rails 7. A transparent cover 9 is fixedly provided on the upper surface of the sliding frame 10. By pushing the transparent cover 9, the sliding frame 10 slides along the slide rails 7, and the transparent cover 9 can also observe the condition of the internal tablets. A concave separation groove 6 is provided on the side of the sliding table 4 between the slide rails 7. The tablets enter the separation groove 6, and then by pushing open the transparent cover 9, the tablets in the separation groove 6 can be taken out.

[0023] See Figure 2 , The depth and shape of the separation groove 6 are such that only one olmesartan medoxomil and hydrochlorothiazide tablet can lie flat inside it, so that the tablets above this tablet can all be pushed towards the medicine outlet 5 when the transparent cover 9 is pushed. The transparent cover 9 covers the medicine outlet 5 and the separation groove 6. The sliding frame 10 is hermetically connected to the slide rails 7, and the left and right side frames of the sliding frame 10 are hermetically connected to the upper surface of the sliding table 4, so as to keep the sliding connection between the transparent cover 9 and the sliding table 4 airtight.

[0024] See Figure 2-3 , A clamping groove 11 is provided on one side of the sliding frame 10 away from the separation groove 6. A lower groove 12 is provided on one side of the sliding table 4 at the medicine outlet 5. A clamping block 14 is fixedly provided in the lower groove 12 through a horizontal elastic rod 13. The position of the clamping block 14 is opposite to that of the clamping groove 11, and inclined sliding surfaces are provided on both sides of the clamping block 14. By squeezing the sliding surfaces, the elastic rod 13 undergoes elastic deformation downward for the sliding frame 10 to pass through. When the clamping block 14 is stuck in the clamping groove 11, the transparent cover 9 covers the medicine outlet 5 and the separation groove 6. After the clamping block 14 is stuck in the clamping groove 11, it can prevent the transparent cover 9 from sliding and keep it in the position covering the medicine outlet 5 and the separation groove 6. The length of the slide rails 7 is such that when the transparent cover 9 slides along the slide rails 7, the separation groove 6 can be exposed.

[0025] The olmesartan medoxomil and hydrochlorothiazide tablet encapsulation device of the present utility model has a simple structure. In view of the shape and characteristics of olmesartan medoxomil and hydrochlorothiazide tablets, the tablets are encapsulated in a bottle body, and single tablets can be taken out when taking medicine, which can avoid problems such as pouring out too many tablets and the tablets getting damp due to frequent opening of the bottle cap. It has strong practicability and is suitable for popularization.

[0026] Specifically, when in use, refer to Figure 1-2, when the olmesartan medoxomil and hydrochlorothiazide tablets are placed in the packaging bottle 1, the sealing cap 2 is connected to the packaging bottle 1 through a sealing thread. When pouring out the tablets, there is no need to open the sealing cap 2. By pushing the transparent cap 9, a tablet can be separated and poured out. The packaging bottle 1 is turned over so that the tablets enter the transparent cap 9 from the medicine outlet 5. Then the packaging bottle 1 is tilted towards the separation groove 6, so that the tablets from the transparent cap 9 slide to the separation groove 6. The packaging bottle 1 is shaken so that the lower tablets fall into the separation groove 6. The depth of the separation groove 6 can only hold one tablet. Then the transparent cap 9 is pushed to slide along the slide rail 7, and the tablets in the transparent cap 9 are pushed towards the medicine outlet 5, thus leaving the tablets in the separation groove 6. After the transparent cap 9 is pushed away, the separation groove 6 is exposed, and the tablets in the separation groove 6 can be poured out;

[0027] See Figure 3 , when the transparent cap 9 is reset, the inclined surface on the clamping block 14 is squeezed, and the elastic rod 13 undergoes elastic deformation downward to allow the sliding frame 10 to pass through. After the clamping block 14 is clamped into the clamping groove 11, the transparent cap 9 can be prevented from sliding.

[0028] The above are only the preferred embodiments of the present utility model and are not used to limit the present utility model. Although the present utility model has been described in detail with reference to the foregoing embodiments, for those skilled in the art, they can still modify the technical solutions recorded in the foregoing embodiments, or perform equivalent replacements for some of the technical features. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principle of the present utility model shall be included within the protection scope of the present utility model.

Claims

1. A packaging device for olmesartan medoxomil and hydrochlorothiazide tablets, comprising a packaging bottle (1) and a sealing cap (2), characterized in that: A sealing ring (8) is fixedly provided below the closing cover (2), and the sealing ring (8) is threadedly connected to the upper end of the packaging bottle (1); the upper part of the closing cover (2) is a contraction cavity (3), and a sliding platform (4) is provided at the top of the contraction cavity (3), and the sliding platform (4) is in the shape of a long strip; A through medicine outlet (5) is provided in the middle of the sliding platform (4), and slide rails (7) are provided on both sides of the sliding platform (4) located in front and behind the medicine outlet (5). A sliding frame (10) is slidably provided on the slide rails (7), and a transparent cover (9) is fixedly provided on the upper surface of the slide frame (10). A concave separation groove (6) is provided on the side of the sliding platform (4) located between the slide rails (7).

2. The Olmesartan Medoxomil Hydrochlorothiazide tablet packaging device according to claim 1, characterized in that: The transparent cover (9) covers the medicine outlet (5) and the separation groove (6), the sliding frame (10) is tightly connected to the slide rail (7), and the left and right side frames of the sliding frame (10) are tightly connected to the upper surface of the sliding platform (4).

3. The Olmesartan Medoxomil Hydrochlorothiazide tablet packaging device according to claim 1, characterized in that: The sliding frame (10) is provided with a card slot (11) on the side away from the separation groove (6), and the sliding platform (4) is provided with a lower groove (12) on the side of the medicine outlet (5). The lower groove (12) is fixed with a card block (14) through a transverse elastic rod (13). The position of the card block (14) is opposite to the card slot (11), and the left and right sides of the card block (14) are provided with inclined sliding surfaces. When the card block (14) is stuck in the card slot (11), the transparent cover (9) covers the medicine outlet (5) and the separation groove (6). The length of the slide rail (7) is sufficient for the transparent cover (9) to slide along the slide rail (7), so that the separation groove (6) can be exposed to the outside.

4. The Olmesartan Medoxomil Hydrochlorothiazide tablet packaging device according to claim 1, characterized in that: The depth and shape of the separation groove (6) are sufficient to allow only one Olmesartan Medoxomil Hydrochlorothiazide tablet to lie flat inside it.

Images